Table 4

Univariate associations of continuous variables with the purchase of complementary medicines in the entire osteoarthritis cohort

Continuous variablesBought complementary medicinesDid not buy complementary medicinest Valuep Value
Values are mean (SD).
*p<0.05.
SF-36, short form 36 item health questionnaire; WOMAC, Western Ontario and McMaster Universities osteoarthritis index.
Age (years)66.4 (9.2)67.4 (9.1)1.0080.31
Disease duration (years)14.4 (11.7)16.0 (11.4)1.2610.21
WOMAC pain5.7 (3.3)4.6 (3.6)−2.9860.003*
WOMAC stiffness3.2 (1.5)2.7 (1.6)−2.8010.005*
WOMAC function21.8 (12.2)18.7 (13.3)−2.2060.028*
SF-36 mental component summary46.1 (5.3)45.8 (5.0)−0.5200.60
SF-36 physical component summary36.8 (9.3)39.6 (9.0)2.4270.016*
SF-36 scale scores
    Mental health 0–10073.3 (14.5)76.8 (15.5)2.0990.037*
    Role emotional66.8 (34.2)71.4 (33.7)1.2030.23
    General health65.6 (16.7)67.5 (18.0)0.9870.33
    Vitality56.3 (14.6)60.0 (18.7)1.9360.054
    Social function68.8 (34.2)71.4 (33.7)1.7170.087
    Physical function47.7 (20.5)53.5 (24.7)2.2510.025*
    Role physical39.3 (50.1)50.3 (37.9)2.2940.022*
    Bodily pain52.5 (20.0)63.3 (22.5)4.4960.001*
Cost of concomitant arthritis medicines (annual, both prescription and non-prescription)$98.27 ($113.35)$64.00 ($142.33)−2.4580.014*